Clinical AAC Research Conference
Call for Papers
Deadline for Abstracts and Papers: JULY 8, 2011
Printable Call for Papers - fillable .doc file
The intent of the CLINICAL AAC RESEARCH CONFERENCE is to strengthen and share the evidence base for clinical practice is AAC. Therefore, platform and poster proposals may take any of these forms: reports of original research, such as clinical trials, group designs, single-subject experiments and case series studies, descriptive research, systematic reviews, and critically appraised topics.
Presentation formats include:
• Platform Presentation (20 minute presentation followed by 10 minutes for discussion)
• Poster Presentation
Proposal formats for platform and poster session are the same. The proposal should be no more than 1200 words in length, excluding references and tables. An additional 150 (maximum) word abstract is required. Abstracts will be included in the conference program.
Your proposal will constitute your application to attend the 2011 CLINICAL AAC RESEARCH CONFERENCE. The same evaluation criteria will be used for both platform and poster presentations. The program committee will determine designation as a poster or platform, though you may select your preference through the proposal process.
All accepted abstract and paper submissions will be archived. By submitting your paper to this conference, you are agreeing to have your abstract and paper made publicly accessible in the CLINICAL AAC RESEARCH CONFERENCE archives. As an author of a paper submitted to this conference, you retain the copyright for your paper posted in the archive, having granted permission for its use on this site. You also retain the right to publish your paper elsewhere (unless expressly forbidden by the publisher).
To allow for a blind review, there should be no identifying information in the body of the submission or in the body of the abstract.
Paper submissions must adhere to APA style and must meet the following requirements:
If possible, all figures and tables should be integrated into a single document submission. The body of the submission must not exceed 1200 words (excluding the end matter). The submission document page format must be 8-1/2" x 11" (or A4), must be single-spaced, in 12-point font (Times New Roman preferred) with margins of 1 inch (2.5 cm).
A single file is expected. The file should include the title, authors, affiliations, abstract, and paper including tables, figures, and references. Content provided to reviewers will not include the authors and affiliations.
The file format must be .txt (text) or .rtf (rich text format). File name should use the form
YYMMDDLASTNAMEN.txt or .rtf.
"YY" is 11(for 2011); "MM" is month (e.g., 02 for February); "DD" is date (14 for the 14th day of the month); "LASTNAME" is the last name of the primary author; "N" designates the order of the proposal(s) submitted by the author (1 for the first proposal, 2 for the second, etc.).
Any proposal containing documents or figures submitted in unreadable formats or not adhering to submission requirements will not be considered.
Proposal forms (copy the form below and paste into a .txt or .rtf document) and proposal files should be sent electronically to Chairs of the Program Committee Drs. Richard Hurtig and Jeff Higginbotham at firstname.lastname@example.org.
Notification of acceptance will be sent by mid July.
2011 CLINICAL AAC RESEARCH CONFERENCE
(Download the Printable Call for Papers - fillable .doc file or copy this form, paste into a .txt or .rtf document, and complete.)
Submission Deadline: Extended to July 8, 2011
Alternative formats for the Proposal Form are available.
Phone (day time):
Biographical Sketch of Primary Author (Limited to 50 words):
Phone (day time):
Phone (day time):
Preferred Presentation Format: (Check only one)
____ Poster Session
____ Program Committee Decision
Document Abstract: (Limit 150 words; no identifying information)
Research Description: (Limit 1200 words; no identifying information) (Should include Introduction/Background Information, Purpose, Methods, Results, Conclusions, Clinical Implications)Return to CAAC